Whereas TTFields treatment alone did not affect the level of cytotoxic CD8+ T lymphocytes (CTLs) in the tumor, significant elevation was displayed in both groups treated with anti-PD-1/anti-CTLA-4 (Figure 2K and Figure S4A). This evidence concerns the gene CD8A and neoplasm.